A. Noske

发表

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.

P. Fasching, A. Schneeweiss, C. Denkert, 2018, The Lancet. Oncology.

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

W. Weichert, A. Stenzinger, C. Denkert, 2011, Endocrine-related cancer.

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

Harald Frick, Joachim Diebold, Mauro G. Mastropasqua, 2012, PloS one.

A prognostic gene expression index in ovarian cancer—validation across different independent data sets

W. Weichert, C. Denkert, M. Dietel, 2009, The Journal of pathology.

Multispectral Optoacoustic Tomography (MSOT) of Human Breast Cancer

E. Rummeny, V. Ntziachristos, Gael Diot, 2017, Clinical Cancer Research.

Polo-like kinase 1 expression is a prognostic factor in human colon cancer.

W. Weichert, G. Kristiansen, C. Denkert, 2005, World journal of gastroenterology.

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

Carsten Denkert, Jan Budczies, Wilko Weichert, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genome-wide Gene Expression Profiling of Formalin-fixed Paraffin-Embedded Breast Cancer Core Biopsies Using Microarrays

Carsten Denkert, Jan Budczies, Wilko Weichert, 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer

W. Weichert, M. Kiechle, A. Hapfelmeier, 2020, Archives of Gynecology and Obstetrics.

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)

C. Denkert, H. Ulmer, R. Wirtz, 2011, Breast Cancer Research and Treatment.

Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue.

Carsten Denkert, Jan Budczies, Wilko Weichert, 2009, Endocrine-related cancer.

Suppression of the TIG3 tumor suppressor gene in human ovarian carcinomas is mediated via mitogen‐activated kinase‐dependent and ‐independent mechanisms

I. Nazarenko, A. Noske, R. Schäfer, 2005, International journal of cancer.

Slug and Sox 9 Cooperatively Determine the Mammary Stem Cell State Citation

Wenjun Guo, Alexander van Oudenaarden, Shalev Itzkovitz, 2022 .

Multi-Spectral Optoacoustic Tomography (MSOT) of human breast cancer.

E. Rummeny, V. Ntziachristos, Gael Diot, 2017 .

Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K–AKT pathway

W. Weichert, P. Schirmacher, A. Stenzinger, 2017, Genes, chromosomes & cancer.

Amelanotic metastasis of melanoma mimicking ovarian cancer: a case report and review of the literature.

A. Noske, J. Sehouli, F. Kiecker, 2008, Anticancer research.

Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology.

W. Weichert, C. Denkert, M. Dietel, 2010, Human pathology.

[NF-kappaB subunit p65/RelA expression in ovarian carcinoma: prognostic impact and link to COX-2 overexpression].

W. Weichert, C. Denkert, M. Dietel, 2007, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

A requirement for p120-catenin in the metastasis of invasive ductal breast cancer

Brian Bierie, A. Noske, W. Muller, 2020, Journal of Cell Science.

Combined adenosquamous and large-cell neuroendocrine carcinoma of the gallbladder

A. Noske, S. Pahl, 2006, Virchows Archiv.

Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas.

W. Weichert, C. Denkert, M. Dietel, 2008, Neoplasia.

Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience

A. Noske, Z. Varga, 2015, PloS one.

Report of a metaplastic carcinoma of the breast with multi-directional differentiation: an adenoid cystic carcinoma, a spindle cell carcinoma and melanoma

G. Kristiansen, M. Dietel, A. Noske, 2008, Virchows Archiv.

IMP3 Expression in Human Ovarian Cancer is Associated With Improved Survival

W. Weichert, C. Denkert, M. Dietel, 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The Prognostic Impact of p53 Expression on Sporadic Colorectal Cancer Is Dependent on p21 Status

J. Budczies, H. Buhr, A. Noske, 2011, Cancers.

Therapeutic potential of CAMPATH‐1H in skeletal tumours

K. Schaser, P. Schlag, A. Noske, 2010, Histopathology.

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

W. Weichert, K. Schlüns, C. Denkert, 2009, Breast Cancer Research.

Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?

A. Noske, R. Caduff, K. Dedes, 2012, Modern Pathology.

The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo

W. Weichert, M. Kiechle, A. Hapfelmeier, 2021, Cancer Immunology Research.

Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State

Wenjun Guo, Alexander van Oudenaarden, Shalev Itzkovitz, 2012, Cell.

Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover

Oliver Fiehn, Tobias Kind, Carsten Denkert, 2008, Molecular Cancer.

KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation

H. Moch, K. Ikenberg, P. Wild, 2014, The Journal of pathology.

Targeted next‐generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance

Jan Budczies, Nicole Pfarr, Volker Endris, 2017, Genes, chromosomes & cancer.

HMGA2 gene is a promising target for ovarian cancer silencing therapy

A. Noske, R. Schäfer, C. Sers, 2008, International journal of cancer.

LACTB is a tumour suppressor that modulates lipid metabolism and cell state

T. Golub, R. Weinberg, Brian Bierie, 2017, Nature.

Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity

Joachim M. Buhmann, Peter J. Wild, Maria Gabrani, 2016, Scientific Reports.

Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2

W. Weichert, C. Denkert, M. Dietel, 2006, Modern Pathology.

Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis?

H. Buhr, A. Noske, J. Haier, 2004, Clinical & Experimental Metastasis.

Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer

H. Moch, P. Wild, A. Noske, 2016, Oncotarget.

Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes.

B. LaFleur, H. Moch, A. Noske, 2015, Experimental and molecular pathology.

ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas

A. Noske, K. Dedes, P. Imesch, 2013, International journal of molecular sciences.

Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer

H. Moch, P. Schraml, A. Noske, 2013, PloS one.

TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.

H. Moch, P. Wild, A. Noske, 2013, Experimental and molecular pathology.

High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo

W. Weichert, G. Kristiansen, C. Denkert, 2009, BMC Cancer.

Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro

H. Moch, K. Ikenberg, A. Noske, 2014, PloS one.

Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.

W. Weichert, P. Schirmacher, A. Stenzinger, 2019, Pathology.

Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo

W. Weichert, C. Denkert, M. Dietel, 2008, Clinical Cancer Research.

Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy

W. Weichert, J. Lauber, J. Martens, 2018, Breast Care.

PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients

A. Walch, E. Gross, M. Kiechle, 2018, International journal of oncology.

Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.

W. Weichert, C. Denkert, M. Dietel, 2007, Cancer letters.

Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis.

W. Weichert, C. Denkert, M. Dietel, 2008, Oncology reports.

A multicentre analytical comparison study of inter‐reader and inter‐assay agreement of four programmed death‐ligand 1 immunohistochemistry assays for scoring in triple‐negative breast cancer

W. Weichert, C. Denkert, M. Kiechle, 2020, Histopathology.

Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer

G. Kristiansen, H. Moch, A. Noske, 2011, Virchows Archiv.

Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study

Holger Moch, H. Moch, A. Noske, 2013, BMC Cancer.

Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer

W. Weichert, K. Schwamborn, M. Kiechle, 2021, Breast.

p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans

H. Moch, K. Ikenberg, P. Wild, 2012, EMBO molecular medicine.

Combination of p 53 expression and p 21 loss has an independent prognostic impact on sporadic colorectal cancer

J. Budczies, C. Loddenkemper, H. Buhr, 2022 .

Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications

W. Weichert, G. Kristiansen, K. Winzer, 2005, Virchows Archiv.

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

D. Lambrechts, I. Tomlinson, P. Wild, 2014, Journal of the National Cancer Institute.

Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro

W. Weichert, C. Denkert, M. Dietel, 2009, Journal of Cancer Research and Clinical Oncology.

CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion

T. Schlange, G. Kristiansen, P. Altevogt, 2011, Clinical & Experimental Metastasis.

Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology

W. Weichert, P. Schirmacher, A. Stenzinger, 2017, Genes, chromosomes & cancer.

Solid neuroendocrine carcinomas of the breast: metastases or primary tumors?

W. Weichert, A. Schneider, A. Noske, 2010, Breast Cancer Research and Treatment.

Diagnostic Accuracy and Prognostic Value of Core Biopsy in the Management of Breast Cancer: A Series of 542 Patients

A. Schneider, A. Noske, C. Richter-Ehrenstein, 2009, International journal of surgical pathology.

Expression of the ELAV-Like Protein HuR Is Associated with Higher Tumor Grade and Increased Cyclooxygenase-2 Expression in Human Breast Carcinoma

W. Weichert, G. Kristiansen, K. Winzer, 2004, Clinical Cancer Research.

Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue

W. Weichert, C. Denkert, M. Dietel, 2009, Virchows Archiv.

CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion

T. Schlange, G. Kristiansen, P. Altevogt, 2011, Clinical & Experimental Metastasis.

Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer.

W. Weichert, A. Stenzinger, C. Denkert, 2010, Human pathology.

Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer

H. Moch, A. Noske, R. Tubbs, 2012, Breast Cancer Research and Treatment.

Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer

A. Noske, K. Dedes, D. Fink, 2017, BMC Cancer.

Expression of multidrug resistance‐associated protein 1 in invasive ovarian carcinoma: implication for prognosis

W. Weichert, C. Denkert, M. Dietel, 2009, Histopathology.

An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas

W. Weichert, C. Denkert, M. Dietel, 2011, BMC Cancer.

Class IHistone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer : Specific Role of Class I Histone Deacetylases In vitro and In vivo

C. Denkert, M. Dietel, A. Noske, 2008 .

Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging

W. Weichert, K. Schwamborn, C. Denkert, 2023, International journal of molecular sciences.

Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing – a case report

H. Moch, P. Wild, A. Noske, 2017, BMC Cancer.

The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations

W. Weichert, A. Noske, B. Haller, 2020, Cancer Immunology, Immunotherapy.

Expression patterns of polo‐like kinase 1 in human gastric cancer

W. Weichert, C. Denkert, M. Dietel, 2006, Cancer science.

Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.

C. Denkert, M. Dietel, J. Budczies, 2013, Human pathology.

Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer

W. Weichert, J. Lauber, A. Noske, 2018, Scientific Reports.

Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis

W. Weichert, C. Denkert, M. Dietel, 2009, Modern Pathology.

Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer

Carsten Denkert, Wilko Weichert, Manfred Dietel, 2008, Cancer.

Loss of MDC1 in Endometrial Carcinoma Is Associated With Loss of MRN Complex and MMR Deficiency

A. Noske, S. Brandt, K. Dedes, 2019, AntiCancer Research.

Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node-positive study.

P. Fasching, W. Weichert, C. Denkert, 2019, European journal of cancer.

The G Protein-Coupled Estrogen Receptor (GPER) Is Expressed in Two Different Subcellular Localizations Reflecting Distinct Tumor Properties in Breast Cancer

A. Noske, Z. Varga, P. Imesch, 2014, PloS one.

De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway

Raphaela Fritsche-Guenther, Manfred Dietel, Peter M Schlag, 2010, Histopathology.

Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study

A. Noske, R. Caduff, K. Dedes, 2012, Reproductive Biology and Endocrinology.

Classification of benign and preinvasive lesions of the breast Benign tumors

A. Noske, A. Kleine-Tebbe, 2010 .

Giardia lamblia and Helicobacter pylori coinfection in gastrointestinal biopsies: A retrospective single-center analysis from Switzerland.

A. Noske, S. Brandt, D. Soldini, 2021, Annals of diagnostic pathology.

Prognostic impact of AMP-activated protein kinase expression in ovarian carcinoma: correlation of protein expression and GC/TOF-MS-based metabolomics.

O. Fiehn, W. Weichert, C. Denkert, 2011, Oncology reports.

Loss of Gelsolin expression in human ovarian carcinomas.

W. Weichert, C. Denkert, M. Dietel, 2005, European journal of cancer.

Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression.

W. Weichert, G. Kristiansen, C. Denkert, 2008, International journal of oncology.

therascreenPITX2 RGQ PCR assay for the assessment of PITX2 DNA-methylation status to investigate the role of the transcription factor PITX2 and the regulation of the Wnt/ß-catenin pathway in pathophysiological processes.

W. Weichert, M. Kiechle, A. Noske, 2018 .

Reproducibility and concordance of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assays in triple-negative breast cancer (TNBC)

W. Weichert, C. Denkert, A. Noske, 2019, Geburtshilfe und Frauenheilkunde.

Overexpression of cyclooxygenase‐2 in human prostate carcinoma and prostatic intraepithelial neoplasia‐association with increased expression of polo‐like kinase‐1

W. Weichert, G. Kristiansen, C. Denkert, 2007, The Prostate.

Comparison of assessment of programmed death-ligand 1 (PD-L1) status in triple-negative breast cancer biopsies and surgical specimens

W. Weichert, M. Kiechle, A. Noske, 2023, Journal of clinical pathology.

Benign and preinvasive breast lesions

A. Noske, A. Kleine-Tebbe, 2010 .

Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results

W. Weichert, M. Kiechle, A. Hapfelmeier, 2019, Breast.

Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer

W. Weichert, J. Lauber, J. Martens, 2018, Scientific Reports.

PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

M. Schwaiger, A. Noske, H. Wester, 2018, EJNMMI Research.

Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.

J. Budczies, C. Loddenkemper, H. Buhr, 2009, Oncology reports.

Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer

H. Moch, A. Noske, S. Brandt, 2017, BMC Cancer.

The Expression of Histone Deacetylase 1, But Not Other Class I Histone Deacetylases, Is Significantly Increased in Endometriosis

A. Noske, P. Imesch, D. Fink, 2013, Reproductive Sciences.

Computer-Assisted Diagnosis of Lymph Node Metastases in Colorectal Cancers Using Transfer Learning With an Ensemble Model.

J. Thiran, I. Nagtegaal, A. Noske, 2023, Modern Pathology.

Expression of lysophosphatidic acid acyltransferase beta (LPAAT-β) in ovarian carcinoma: correlation with tumour grading and prognosis

W. Weichert, C. Denkert, M. Dietel, 2005, British Journal of Cancer.